GlassScriptPhysician profile
Brian Donald Wright
NPI 1912018326
$9,610.96
in general payments reported to CMS, 2019-2025
31 companies · $1,496 in 2025
The $1,496 reported for 2025 was more than what 85% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,402 · 2020: $488 · 2021: $1,488 · 2022: $1,779 · 2023: $1,422 · 2024: $1,537 · 2025: $1,496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,454.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $4,060.66 | 2019-2025 | Clareon, Wavelight Plus, Wavelight Refractive Suite |
| Sun Pharmaceutical Industries INC. | $1,229.16 | 2019-2025 | Cequa |
| Abbvie INC. | $549.03 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Johnson & Johnson Surgical Vision, INC. | $411.98 | 2019-2025 | Catalys System, Tecnis Iol, Tecnis Iol |
| Carl Zeiss Meditec USA, INC. | $404.94 | 2021-2022 | |
| Allergan, INC. | $391.86 | 2019-2022 | |
| Johnson & Johnson Vision Care, INC. | $274.93 | 2024-2025 | Acuvue |
| Oyster Point Pharma, INC. | $235.46 | 2022-2025 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $229.31 | 2019-2023 | |
| Glaukos Corporation | $194.74 | 2021-2023 | Photrexa Cross-Linking Kit, Iaccess Precision Blade, Istent Inject Trabecular Micro-Bypass System Model G2-M-Is |
| Sight Sciences, INC. | $172.06 | 2019-2021 | |
| Optos, INC. | $167.81 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $163.95 | 2023-2025 | Infuse, Envista Envy Iol, Miebo |
| Dompe US, INC. | $156.54 | 2024 | Oxervate |
| New World Medical,INC. | $126.51 | 2019-2023 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $111.44 | 2024-2025 | Vevye |
| Shire North American Group INC | $85.19 | 2019 | |
| Beaver-Visitec International, INC. | $84.19 | 2022 | |
| Biotissue Holdings INC. | $82.74 | 2019 | |
| Aerie Pharmaceuticals, INC. | $68.56 | 2020-2021 | |
| Carl Zeiss Meditec, INC. | $64.71 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $57.83 | 2024 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $55.94 | 2019-2021 | |
| Eyevance Pharmaceuticals LLC | $49.85 | 2019-2021 | |
| Ocular Therapeutix, INC. | $39.39 | 2023-2024 | Dextenza |
| Kala Pharmaceuticals, INC. | $38.29 | 2021 | |
| Lensar, INC. | $27.27 | 2022 | |
| Thea Pharma INC. | $20.95 | 2023 | Iyuzeh |
| Coopervision INC. | $19.75 | 2025 | Myday Contact Lens |
| Rayner Intraocular Lenses Limited | $18.48 | 2024 | Rayone Emv, Omidria, Rayone Aspheric |
| Galderma Laboratories, L.P. | $17.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.